JP Morgan Chase’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

JP Morgan Chase’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-867	Closed	-$26K	–	6990
2021 Q2	$26K	Hold	867	–	–	﹤0.01%	5888
2021 Q1	$28K	Buy	867 +289	+50%	+$9.73K	﹤0.01%	5655
2020 Q4	$21K	Sell	578 -380	-40%	-$14.3K	﹤0.01%	5295
2020 Q3	$36K	Buy	958 +730	+320%	+$26.4K	﹤0.01%	5032
2020 Q2	$8K	Buy	+228	New	+$8.1K	﹤0.01%	5154
2019 Q3	–	Sell	-582	Closed	-$12K	–	6052
2019 Q2	$12K	Hold	582	–	–	﹤0.01%	5543
2019 Q1	$10K	Hold	582	–	–	﹤0.01%	5548
2018 Q4	$7K	Sell	582 -4,895	-89%	-$64.2K	﹤0.01%	5502
2018 Q3	$90K	Buy	5,477 +4,895	+841%	+$73.9K	﹤0.01%	4993
2018 Q2	$7K	Buy	+582	New	+$8.84K	﹤0.01%	5412

Other funds holding ZEAL

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JCM

Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

JP Morgan Chase's ZEAL Position: Q3 2021 in Review

JP Morgan Chase sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2021, closing a stake of 867 shares — an estimated $26K sold.

JP Morgan Chase first reported a position in ZEAL in Q2 2018 and held it in 10 quarters. The position peaked at $90K in Q3 2018. 14 funds tracked by Wall St. Rank hold ZEAL as of Q3 2021.

JP Morgan Chase reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2021 after selling out during the quarter.
JP Morgan Chase sold 867 Zealand Pharma A/S American Depositary Shares shares in Q3 2021, an estimated $26K.
JP Morgan Chase first reported a position in Zealand Pharma A/S American Depositary Shares in Q2 2018 and held it in 10 quarters.
JP Morgan Chase's Zealand Pharma A/S American Depositary Shares position peaked at $90K in Q3 2018.
14 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2021.

Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.